Vertex Pharmaceuticals

company

About

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

  • 1001 - 5000

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$5.80M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1989
Number Of Employee
1001 - 5000
Operating Status
Active

Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.80M
Vertex Pharmaceuticals has raised a total of $5.80M in funding over 2 rounds. Their latest funding was raised on Jul 17, 1989 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 17, 1989 Series Unknown $5.80M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Vertex Pharmaceuticals is funded by 1 investors. Norwest Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Series Unknown